We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+14.45%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$43.5B
AUM Growth
+$6.37B
Cap. Flow
+$123M
Cap. Flow %
0.28%
Top 10 Hldgs %
9.32%
Holding
3,484
New
550
Increased
1,237
Reduced
1,116
Closed
366

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$301M
2
TSLA icon
Tesla
TSLA
+$254M
3
NKE icon
Nike
NKE
+$248M
4
PG icon
Procter & Gamble
PG
+$233M
5
PFE icon
Pfizer
PFE
+$232M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 10.23%
3 Consumer Discretionary 10.17%
4 Healthcare 10.17%
5 Industrials 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCBX icon
2726
Third Coast Bancshares
TCBX
$738M
$236K ﹤0.01%
11,879
-7,487
-39% -$130K
VOTE icon
2727
TCW Transform 500 ETF
VOTE
$1.14B
$234K ﹤0.01%
+4,200
New +$218K
MLTX icon
2728
MoonLake Immunotherapeutics
MLTX
$1.55B
$233K ﹤0.01%
3,853
FNA
2729
DELISTED
Paragon 28, Inc.
FNA
$233K ﹤0.01%
+18,719
New +$198K
BNTX icon
2730
BioNTech
BNTX
$23.5B
$232K ﹤0.01%
2,200
-6,100
-73% -$615K
FRME icon
2731
First Merchants
FRME
$2.67B
$232K ﹤0.01%
6,249
-69,261
-92% -$2.15M
PHVS icon
2732
Pharvaris
PHVS
$2.44B
$230K ﹤0.01%
+8,198
New +$166K
ETON icon
2733
Eton Pharmaceutcials
ETON
$1.22B
$230K ﹤0.01%
52,500
-27,052
-34% -$108K
AKBA icon
2734
Akebia Therapeutics
AKBA
$252M
$230K ﹤0.01%
185,399
+157,938
+575% +$161K
XERS icon
2735
Xeris Biopharma Holdings
XERS
$1.45B
$229K ﹤0.01%
97,349
-12,577
-11% -$23.2K
INZY
2736
DELISTED
Inozyme Pharma
INZY
$229K ﹤0.01%
53,700
-14,400
-21% -$51.2K
SLDB icon
2737
Solid Biosciences
SLDB
$900M
$228K ﹤0.01%
+37,198
New +$119K
TVRD
2738
Tvardi Therapeutics
TVRD
$23.4M
$228K ﹤0.01%
8,535
+6,597
+340% +$273K
QCRH icon
2739
QCR Holdings
QCRH
$1.7B
$228K ﹤0.01%
+3,905
New +$202K
RRGB icon
2740
Red Robin
RRGB
$152M
$227K ﹤0.01%
18,208
-43,669
-71% -$407K
KREF
2741
KKR Real Estate Finance Trust
KREF
$499M
$227K ﹤0.01%
+17,133
New +$205K
WSBC icon
2742
WesBanco
WSBC
$4B
$226K ﹤0.01%
7,200
-71,218
-91% -$1.91M
EH
2743
EHang Holdings
EH
$435M
$226K ﹤0.01%
13,435
+1,935
+17% +$31.6K
MFA
2744
MFA Financial
MFA
$933M
$226K ﹤0.01%
20,017
-3,876
-16% -$39.2K
UMBF icon
2745
UMB Financial
UMBF
$11.1B
$226K ﹤0.01%
2,700
-5,429
-67% -$382K
IFRX icon
2746
InflaRx
IFRX
$271M
$226K ﹤0.01%
138,375
+125,950
+1,014% +$216K
IVVD icon
2747
Invivyd
IVVD
$218M
$224K ﹤0.01%
+56,854
New +$108K
RERE
2748
ATRenew
RERE
$1.01B
$224K ﹤0.01%
116,516
+89,900
+338% +$158K
HWC icon
2749
Hancock Whitney
HWC
$6.24B
$224K ﹤0.01%
4,600
-71,074
-94% -$2.84M
SGU icon
2750
Star Group
SGU
$423M
$223K ﹤0.01%
+19,360
New +$235K

Similar funds

Two Sigma Investments's Q4 2023 Portfolio in Review

As of Q4 2023, Two Sigma Investments held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Two Sigma Investments's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Two Sigma Investments's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
  • Two Sigma Investments added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
  • Two Sigma Investments's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
  • Two Sigma Investments fully exited Tesla in Q4 2023, selling an estimated $254M.
  • Two Sigma Investments's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
  • Two Sigma Investments opened 550 new positions and closed 366 in Q4 2023.
  • Two Sigma Investments's portfolio value rose 17% quarter-over-quarter to $43.5B.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.